CHRU Besançon - Jean Minjoz
Rouen, Cedex 25030
0 studies enrolling now · 1 studies all time
What they study most
Metastatic Melanoma
Studies at this site
A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma
— Stopped early